Mutation-Based Therapy for Duchenne Muscular Dystrophy: Antisense Treatment Arrives in the Clinic.
Elizabeth M. McNally, Eugene J. Wyatt.
Circulation. 2017;136:979-981.
doi:CIRCULATIONAHA.117.028382
- Home
-
Products and Applications
-
Morpholino Antisense Oligos
- Why Morpholinos?
- Optimal Target Choice
- Methods/Protocols
- Morpholino Products and Properties
- End Modifications and Controls
- Blocking miRNAs
- Blocking Localization Elements of mRNA
- Modify poly-A Tailing
- Other targets: ncRNA, repeat elements, etc.
- External guides for use with RNase P
- Diagnostics
- Uses for Pretargeting & Crosslinking
- Therapeutics
- Bacteria Applications
- Protist Applications
- Insect Applications
-
Morpholino Antisense Oligos
- Ordering
- Customer Support
- Morpholino Publications Database
- FAQ
- About Us
- Contact Us
Add new comment